Sangamo Therap
SGMO----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Sangamo Therap(SGMO) the Revenue is 1.442 M (-77.6%);the EBIT is -31.95 M (-7.82%);the EPS is -0.0796 (+42.73%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B77.60%
----
----
EBIT
-0.03B7.82%
----
----
EPS
-0.079642.73%
----
----
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly